Skip to content

Clinical study of blood pressure and quality of life of patients with phlegm and dampness hypertension

Clinical study of blood pressure and quality of life of patients with phlegm and dampness hypertension

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001038
Enrollment
Unknown
Registered
2026-04-22
Start date
2025-04-01
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Control Group:Basic interventions: basic interventions in health education, diet and exercise control to help patients develop healthy and good living habits. All enrolled patients established a WeCha
Trail Group:On the basis of the control group, the three-part can method of heaven and man and earth was used

Sponsors

Jiangsu Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) The patient is 18~75 years old; (2) Meet the diagnostic criteria of hypertension in Western medicine; (3) Meet the TCM diagnostic criteria for phlegm and damp hypertension; (4) Signed informed consent before operation; (5) Those who are resistant to canning.

Exclusion criteria

Exclusion criteria: 1) Combined with heart, brain, liver, kidney and other organ dysfunction, or acute and malignant diseases such as coronary heart disease, acute coronary syndrome, malignant tumors, etc.; (2) Those with hematopoietic system diseases, diabetes, proteinuria and other diseases; (3) Pregnant, lactating or having a birth plan; (4) Those who have infection or skin ulceration at the implementation site, or those who are highly allergic to the skin and cannot tolerate canning.

Design outcomes

Primary

MeasureTime frame
blood pressure;24-hour ambulatory blood pressure monitoring;Traditional Chinese medicine symptom score;Duchenne Hypertension Quality of Life Scale;

Secondary

MeasureTime frame
abdominal circumference;Laboratory indicators (triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C));Adverse reactions;

Countries

China

Contacts

Public ContactSun Qingxia

Jiangsu Provincial Hospital of Chinese Medicine

13705159904@163.com13705159904

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026